Imperial College London

ProfessorAndreaFrilling

Faculty of MedicineDepartment of Surgery & Cancer

Chair in Endocrine Surgery
 
 
 
//

Contact

 

+44 (0)20 3313 3210a.frilling

 
 
//

Location

 

BN2/13 B BlockHammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Hofland:2022:10.1111/jne.13060,
author = {Hofland, J and Lamarca, A and Steeds, R and Toumpanakis, C and Srirajaskanthan, R and Riechelmann, R and Panzuto, F and Frilling, A and Denecke, T and Christ, E and Grozinsky-Glasberg, S and Davar, J},
doi = {10.1111/jne.13060},
journal = {Journal of Neuroendocrinology},
pages = {1--11},
title = {Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)},
url = {http://dx.doi.org/10.1111/jne.13060},
volume = {34},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - BackgroundThis European Neuroendocrine Tumor Society (ENETS) Expert Consensus document aims to provide practical guidance and standardization for echocardiography in the screening and follow-up of carcinoid heart disease (CHD) in patients with a neuroendocrine tumour (NET) and carcinoid syndrome.MethodsNET experts within the ENETS Carcinoid Heart Disease Task Force reviewed both general reporting guidelines and specialized scoring systems for transthoracic echocardiography (TTE) in CHD. Based on this review, a dedicated template report was designed by the multidisciplinary working group of cardiologists, oncologists, endocrinologists, gastroenterologists, surgeons and radiologists.ResultsWe propose a Synoptic Reporting of Echocardiography in Carcinoid Heart Disease which represents an agreed peer reviewed proforma to capture information at the time of referral and enable a detailed outcome of CHD assessment. This includes a systematic and detailed list of structures to evaluate data to capture at the time of reporting of TTE.ConclusionsAdherence to these reporting guidelines aims to promote homogeneous and detailed evaluation of CHD to secure accurate assessment and allow comparison of studies performed intra- and inter-individually. These guidelines could also facilitate CHD assessment as part of prospective clinical trials to enable standardization of the findings seen in response to therapy.
AU - Hofland,J
AU - Lamarca,A
AU - Steeds,R
AU - Toumpanakis,C
AU - Srirajaskanthan,R
AU - Riechelmann,R
AU - Panzuto,F
AU - Frilling,A
AU - Denecke,T
AU - Christ,E
AU - Grozinsky-Glasberg,S
AU - Davar,J
DO - 10.1111/jne.13060
EP - 11
PY - 2022///
SN - 0953-8194
SP - 1
TI - Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)
T2 - Journal of Neuroendocrinology
UR - http://dx.doi.org/10.1111/jne.13060
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000722638700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - https://onlinelibrary.wiley.com/doi/10.1111/jne.13060
UR - http://hdl.handle.net/10044/1/92853
VL - 34
ER -